About: Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 March 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en marzu de 2020 (ast) scientific article published on 17 March 2020 (en) artykuł naukowy opublikowany 17 marca 2020 (pl) наукова стаття, опублікована 17 березня 2020 (uk)
publication date	wds:Q90516574-8728722D-A48A-44EE-A8F1-CEF5200C195B
publication date	2020-03-17 00:00:00Z (xsd:dateTime)
cites work	wds:Q90516574-01917AC1-A1FE-42CF-B6EA-2AB7FB52ECFC wds:Q90516574-02D45234-23B5-4830-8ED3-12A7A2FE7DE2 wds:Q90516574-1EF22300-3D01-4FC4-9175-29B69B383C1C wds:Q90516574-24CBA464-8879-472D-ADEF-E84417E95536 wds:Q90516574-33F4E3EE-775E-48DE-BA99-658FA4FA2313 wds:Q90516574-3C520BD7-2D83-450A-BDA1-00309C659B1C wds:Q90516574-407177AB-7862-4A87-B387-E15280EEF111 wds:Q90516574-477C3496-4563-4ED3-81ED-69D42C817086 wds:Q90516574-4EC2AC03-5CBE-4922-BB68-B450A799C35C wds:Q90516574-5820A182-DFB4-4CDD-BAFE-3D5074C9742A wds:Q90516574-5C7758D4-1620-4B6F-89D1-ABF4922663F8 wds:Q90516574-63621F92-4B34-46FF-B600-148E4CB7E950 wds:Q90516574-650C4664-10E5-44D0-866E-BFE860C4EA52 wds:Q90516574-6722A411-9CBF-429F-8F2D-CA6B81B01848 wds:Q90516574-7DFF78B9-8581-4FD8-822F-AF8273976F4C wds:Q90516574-7FE9C1D2-052F-411F-ACA5-6C84825EE6EB wds:Q90516574-876675D2-1C57-429C-A3B4-6307397A3B5C wds:Q90516574-8B66FED2-C6FC-4B12-B33F-FFAE4503D82D wds:Q90516574-8E998D9A-CF96-41C5-AF1D-88096235A941 wds:Q90516574-A5F325DA-0265-4332-AC6F-7BC930ED7BFD wds:Q90516574-B736858D-C84B-4B3F-941C-61D1A854ECAF wds:Q90516574-C90C6C98-F092-485A-B7BE-2583D77C1CB7 wds:Q90516574-D27D8CCE-15B0-4C91-B38A-C5C0AFCF37AD wds:Q90516574-E84FD1F4-72C8-4EB3-9272-AA570CB32537 wds:Q90516574-F5F1E4AB-A790-4DB9-8149-67D1FB7D6F9F wds:Q90516574-FB355E73-E261-47A6-966A-13093C3951AC
cites work	Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development Dengue The global distribution and burden of dengue Refining the global spatial limits of dengue virus transmission by evidence-based consensus Dengue: a continuing global threat Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3 Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax). Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy Dengue A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone Assessing the effects of interventions for Aedes aegypti control: systematic review and meta-analysis of cluster randomised controlled trials Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003 Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study Dengue: a growing threat requiring vaccine development for disease prevention Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate
author name string	wds:Q90516574-0E067F2B-4049-4638-A1CE-8D2DE1EC41C0 wds:Q90516574-1B4704D1-7B46-4C15-A103-E426ACD9316C wds:Q90516574-3669B840-43D9-4F42-B9D4-6EDFC481BD00 wds:Q90516574-3E70D193-7DC5-4EE8-85A7-7B1D204DB7FC wds:Q90516574-5E1DE7E7-50F8-4CEE-94F4-CA2B6390746B wds:Q90516574-601734A2-95A9-45EA-AE5D-8AD769688737 wds:Q90516574-6D072C78-8DE7-4468-A426-FB486C6BB0A6 wds:Q90516574-6E62D8A4-ACD4-4BBD-AE0E-2760249ACA59 wds:Q90516574-6FF20F55-3BE5-4C94-B6AB-02D1EF5E5B52 wds:Q90516574-723A32BD-F310-4846-BD06-06514194D744 wds:Q90516574-7476E88F-011A-4D19-BA12-288684C70C0F wds:Q90516574-7F9BBC3C-262D-42F4-9ABB-14D0EC92B1B9 wds:Q90516574-8D780AB7-B97C-4B58-AB95-E624ACA55AC1 wds:Q90516574-8F220A69-F7BC-418D-8AA9-95B773E95E14 wds:Q90516574-95F8AB04-2491-45D8-9F69-FA4EA4B0D54A wds:Q90516574-968DAEF2-F148-4816-8172-C76FB452AD6F wds:Q90516574-96A3EAE5-DBDE-4B0D-860B-AE1B82A1AC42 wds:Q90516574-AD57C522-E3C5-46D2-9E0A-195FE6FE5C9A wds:Q90516574-AE9F7BF9-6783-4E01-A209-C6FBEA0B963A wds:Q90516574-D84146CD-7DD8-46AC-B90B-4C0776B1B000 wds:Q90516574-E6FCBE2D-A8B0-4DFE-9604-AC705E992BED wds:Q90516574-FF3B0458-A592-4960-9037-046B36F4ECBD
author name string	Charissa Borja-Tabora Yanee Hutagalung Svetlana Bizjajeva Felix Espinoza Martina Rauscher Edson Duarte Moreira V Pujitha Wickramasinghe Asvini D Fernando Eduardo López-Medina Maria Theresa Alera Derek Wallace Pedro Garbes Xavier Saez-Llorens Suely Tuboi Delia Yu Dulanie Gunasekera Edith Johana Rodriguez-Arenales Hector Velásquez

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software